CMIC Group was founded in 1985 in Tokyo, Japan and in 1992 became Japan's first Contract Research Organization. By 2001, CMIC Group had launched CRO operations in Korea and China. CRO efforts are primarly focused in SouthEast Asia, particularly Japan, South Korea, China, Singapore and Malaysia. However, the company's long term strategy includes focusing on the expansion of CRO operations in Europe and The united States. In support of this strategy, Contract Manufacturing Operations were launched in the United States in 2007. CMIC Group specializes in the planning, management, and execution of clinical trials from early phase studies through Phase IIb-IV and post approval. The company claims to have a unique business model they term "Pharmaceutical Value Creator" PVC.
CMIC Group is positioned to support Japanese companies expanding into the US and Europeanmarkets while simultaneously assisting foreign companies entering the Japanese market. Our panel viewed CMIC Group as.................................
<Thumbnail and link to interactive dashboard to research more...>